TATTENHAM HEALTH CENTRE
TATTENHAM CRESCENT, EPSOM
HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 2 | 2 | 100.0% | |
| HF 4 | 2011 | 3 | 4 | 75.0% | |
| HF 4 | 2012 | 3 | 5 | 60.0% | |
| HF 4 | 2013 | 2 | 3 | 66.7% | |
| HF004 | 2014 | 1 | 1 | 100.0% | |
| HF004 | 2015 | 2 | 2 | 100.0% | |
| HF004 | 2016 | 3 | 3 | 100.0% | |
| HF004 | 2017 | 3 | 3 | 100.0% | |
| HF004 | 2018 | 4 | 4 | 100.0% | |
| HF004 | 2019 | 4 | 4 | 100.0% | |
| HF004 | 2020 | 6 | 6 | 100.0% | |
| HF006 | 2021 | 21 | 25 | 84.0% | |
| HF006 | 2022 | 24 | 24 | 100.0% | |
| HF006 | 2023 | 42 | 44 | 95.5% |
